Prescient Therapeutics Ltd (PTX) — Capital Reinvestment Ratio
Latest as of June 1993:
0.32x
Prescient Therapeutics Ltd (PTX) has a Capital Reinvestment Ratio of 0.32x as of June 1993, meaning it reinvests 0% of its operating cash flow (AU$1.74 Million) in capital expenditures (AU$562.00K). See PTX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.32x
Capex / Operating Cash Flow
Operating Cash Flow
AU$1.74 Million
AUD
Capital Expenditures
AU$562.00K
AUD
Data as of
Jun 1993
Most recent filing
Prescient Therapeutics Ltd Capital Reinvestment Ratio (1991–1993)
This chart tracks Prescient Therapeutics Ltd's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Prescient Therapeutics Ltd (1991–1993)
Year-by-year Capital Reinvestment Ratio for Prescient Therapeutics Ltd from 1991 to 1993. For live market cap and broader valuation context, see Prescient Therapeutics Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 1993 | 0.32x | AU$1.74 Million | AU$562.00K | ▼ -12.3% |
| 1991 | 0.37x | AU$730.00K | AU$269.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow